论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

A machine learning model for diagnosing acute pulmonary embolism and comparison with Wells score,revised Geneva score,and Years algorithmOACSTPCDMEDLINE

中文摘要

Background:Acute pulmonary embolism(APE)is a fatal cardiovascular disease,yet missed diagnosis and misdiagnosis often occur due to non-specific symptoms and signs.A simple,objective technique will help clinicians make a quick and precise diagnosis.In population studies,machine learning(ML)plays a critical role in characterizing cardiovascular risks,predicting outcomes,and identifying biomarkers.This work sought to develop an ML model for helping APE diagnosis and compare it against current clinical probability assessment models.Methods:This is a single-center retrospective study.Patients with suspected APE were continuously enrolled and randomly divided into two groups including training and testing sets.A total of 8 ML models,including random forest(RF),Naïve Bayes,decision tree,K-nearest neighbors,logistic regression,multi-layer perceptron,support vector machine,and gradient boosting decision tree were developed based on the training set to diagnose APE.Thereafter,the model with the best diagnostic performance was selected and evaluated against the current clinical assessment strategies,including the Wells score,revised Geneva score,and Years algorithm.Eventually,the ML model was internally validated to assess the diagnostic performance using receiver operating characteristic(ROC)analysis.Results:The ML models were constructed using eight clinical features,including D-dimer,cardiac troponin T(cTNT),arterial oxygen saturation,heart rate,chest pain,lower limb pain,hemoptysis,and chronic heart failure.Among eight ML models,the RF model achieved the best performance with the highest area under the curve(AUC)(AUC=0.774).Compared to the current clinical assessment strategies,the RF model outperformed the Wells score(P=0.030)and was not inferior to any other clinical probability assessment strategy.The AUC of the RF model for diagnosing APE onset in internal validation set was 0.726.Conclusions:Based on RF algorithm,a novel prediction model was finally constructed for APE diagnosis.When compared to the current clinical assessment strategies,the RF model achieved better diagnostic efficacy and accuracy.Therefore,the ML algorithm can be a useful tool in assisting with the diagnosis of APE.

Linfeng Xi;Han Kang;Mei Deng;Wenqing Xu;Feiya Xu;Qian Gao;Wanmu Xie;Rongguo Zhang;Min Liu;Zhenguo Zhai;Chen Wang;

Capital Medical University,Beijing 100069,China National Center for Respiratory Medicine,State Key Laboratory of Respiratory Health and Multimorbidity,National Clinical Research Center for Respiratory Diseases,Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,ChinaInstitute of Advanced Research,Infervision Medical Technology Co.,Ltd.,Beijing 100025,ChinaDepartment of Radiology,China-Japan Friendship Hospital,Beijing 100029,China Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Radiology,Peking University China-Japan Friendship School of Clinical Medicine,Beijing 100191,ChinaNational Center for Respiratory Medicine,State Key Laboratory of Respiratory Health and Multimorbidity,National Clinical Research Center for Respiratory Diseases,Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,ChinaDepartment of Radiology,China-Japan Friendship Hospital,Beijing 100029,China

计算机与自动化

Acute pulmonary embolism;Machine learning;Wells score;Revised Geneva score;Years algorithm

《Chinese Medical Journal》 2024 (006)

P.676-682 / 7

supported by grants from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(No.2021-I2M-1-049);the Elite Medical Professionals Project of China-Japan Friendship Hospital(No.ZRJY2021-BJ02);the National High Level Hospital Clinical Research Funding(No.2022-NHLHCRF-LX-01).

10.1097/CM9.0000000000002837

评论

下载量:0
点击量:0